KeyBank National Association’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$706K Buy
27,887
+4,946
+22% +$113K ﹤0.01% 766
2026
Q1
$491K Buy
22,941
+458
+2% +$9.53K ﹤0.01% 842
2025
Q4
$481K Buy
22,483
+157
+0.7% +$3.22K ﹤0.01% 826
2025
Q3
$374K Buy
22,326
+6,560
+42% +$98.3K ﹤0.01% 915
2025
Q2
$226K Buy
+15,766
New +$216K ﹤0.01% 1086
2014
Q1
– Sell
-14,914
Closed -$796K – 1288
2013
Q4
$796K Sell
14,914
-8,818
-37% -$473K 0.01% 737
2013
Q3
$1.19M Buy
23,732
+208
+0.9% +$10.2K 0.01% 560
2013
Q2
$1.08M Buy
+23,524
New +$1.05M ﹤0.01% 771

Other funds holding MD

KeyBank National Association's MD Position: Q2 2026 in Review

KeyBank National Association increased its Pediatrix Medical (MD) stake by 22% in Q2 2026, buying an estimated $113K and bringing the position to 27,887 shares worth $706K. The position accounts for ﹤0.01% of the portfolio, ranked #766.

KeyBank National Association first reported a position in MD in Q2 2013 and has held it in 8 quarters since. The position peaked at $1.19M in Q3 2013. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • KeyBank National Association held 27,887 shares of Pediatrix Medical worth $706K as of Q2 2026.
  • KeyBank National Association bought 4,946 Pediatrix Medical shares in Q2 2026, an estimated $113K.
  • Pediatrix Medical made up ﹤0.01% of KeyBank National Association's portfolio in Q2 2026, its #766 holding.
  • KeyBank National Association first reported a position in Pediatrix Medical in Q2 2013 and has held it in 8 quarters since.
  • KeyBank National Association's Pediatrix Medical position peaked at $1.19M in Q3 2013.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on KeyBank National Association's 13F filing for Q2 2026, filed 28 Jul 2026.